IL6 and pancreatic neoplasm: We have already identified interleukin-6 as a soluble factor highly secreted by CAFs (> 1 ng secreted per 106 CAFs, Supplementary Figure 5A), but not by pancreatic cancer cells, and whose translation / secretion is inhibited by CAF treatment with SOM230 [17].